Mostro announced the release of its version 0.18.5, which introduces critical security fixes and optimizations in order management. NIP-44 is established as the default transport method for communications in Nostr. The development team urged all node operators to update their systems as soon as possible. The update also resolves multiple issues in the collateral system, improving payment management for buyers, the publication of the order book, and the processing of payments for each settled order. Incorrect penalties on sellers' collateral were corrected by anchoring wait times to the exact moment the order is taken. The team thanked the Bitcoin Red Team and the Greybound Team for their reports, which helped identify and resolve vulnerabilities in the code before they could be exploited. Mostro, launched in early 2024, operates as a decentralized intermediary for buying and selling bitcoin using contracts held on the Lightning network and the Nostr communication network, functioning without a central server and without requiring KYC identification processes.
This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.









Moderna shares more than doubled on 19 August 2026 after Merck and Moderna said the Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA met its recurrence-free survival endpoint in resected melanoma. This page explains what the result is, why the stock reacted this hard, what is still unknown, which dates come next (presentation and earnings, both unconfirmed), and what a trader can actually do on WEEX — which does not list Moderna; the nearest instrument is the XBI-USDT biotech ETF perpetual. No price targets, no forecasts.















Long-end U.S. Treasury yields surged to multi-year highs, pressuring technology, semiconductor, storage, and optical communication stocks and driving a clear cooling in market risk appetite. At the same time, Anthropic’s revenue came in below some bullish expectations, prompting investors to reassess the AI growth narrative; Unitree Robotics officially listed on the STAR Market, extending momentum in robotics and embodied AI; while SpaceX and other commercial space names showed relative resilience. Investors are now focused on tonight’s Federal Reserve minutes for clearer signals on the policy path and broader market sentiment.





